Advertisement

Topics

uniQure N.V.: uniQure Announces 2017 Financial Results and Recent Company Progress

07:04 EDT 14 Mar 2018 | FinanzNachrichten

~ On Track to Begin Pivotal Study of AMT-061 in Hemophilia B in Q3 2018 ~ Submitted IND Amendment for AMT-061 Dose Confirmation Study, with Topline Data Expected by End of 2018 ~ Expects IND Submi...

Original Article: uniQure N.V.: uniQure Announces 2017 Financial Results and Recent Company Progress

NEXT ARTICLE

More From BioPortfolio on "uniQure N.V.: uniQure Announces 2017 Financial Results and Recent Company Progress"

Advertisement
Quick Search
Advertisement
Advertisement